In this episode, TRC Healthcare editors, Sara Klockars, PharmD, BCPS, and Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC, discuss notable new meds of 2024. 

Listen in as our editors discuss several novel drugs approved in 2024...and highlight some medications now available in a new dosage form. They’ll review efficacy, safety, and considerations for use with these new treatment options.  

None of the speakers have anything to disclose. 

TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: 

• On Demand Webinar: Notable New Meds of 2024
• Articles: 
  • Clarify the Role of Sofpironium for Hyperhidrosis
  • Watch for Ensifentrine for COPD
  • Don’t Rush to Aprocitentan for Resistant Hypertension
  • New Drug for Schizophrenia Targets Muscarinic Receptors
  • Be Familiar With Carbidopa/Levodopa Options
• New Drug Overviews:
  • Aprocitentan (Tryvio)
  • Epinephrine Nasal Spray (Neffy)
  • Xanomeline/Trospium (Cobenfy)
• FAQ: Emergency Epinephrine Devices
• Chart: Drugs fo

Send a text

Email us: [email protected].

The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

Learn more about our product offerings at trchealthcare.com.